Atg5 | Rat | (+)-Tetrandrine | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | tetrandrine results in increased expression of ATG5 protein | CTD | PMID:26822499 |
Atg5 | Rat | (+)-Tetrandrine | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | tetrandrine results in decreased expression of ATG5 protein | CTD | PMID:25266202 |
Atg5 | Rat | (-)-citrinin | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Citrinin results in increased expression of ATG5 mRNA | CTD | PMID:22771370 |
Atg5 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATG5 mRNA and TFEB protein affects the reaction [epigallocatechin gallate results in increased expression of ATG5 protein] | CTD | PMID:22079256 and PMID:39313106 |
Atg5 | Rat | (-)-epigallocatechin 3-gallate | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | epigallocatechin gallate results in increased expression of ATG5 protein | CTD | PMID:39313106 |
Atg5 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATG5 mRNA | CTD | PMID:22206623 |
Atg5 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Atg5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ATG5 mRNA | CTD | PMID:22206623 |
Atg5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Atg5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ATG5 mRNA | CTD | PMID:21570461 |
Atg5 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATG5 mRNA | CTD | PMID:33387578 |
Atg5 | Rat | 2-(tert-butylimino)-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | buprofezin results in increased expression of ATG5 mRNA | CTD | PMID:36287832 |
Atg5 | Rat | 2-hydroxyethyl methacrylate | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of ATG5 protein] more ... | CTD | PMID:28184909 |
Atg5 | Rat | 2-hydroxyethyl methacrylate | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | hydroxyethyl methacrylate results in increased expression of ATG5 protein | CTD | PMID:28184909 |
Atg5 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of ATG5 mRNA | CTD | PMID:30851411 |
Atg5 | Rat | 3,3',5-triiodo-L-thyronine | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Triiodothyronine results in increased expression of ATG5 mRNA and Triiodothyronine results in increased expression of ATG5 protein | CTD | PMID:30209975 |
Atg5 | Rat | 3,3',5-triiodo-L-thyronine | affects response to substance | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein affects the susceptibility to Triiodothyronine | CTD | PMID:30209975 |
Atg5 | Rat | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of ATG5 protein | CTD | PMID:34915118 |
Atg5 | Rat | 3-hydroxybutyric acid | increases abundance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein results in increased abundance of 3-Hydroxybutyric Acid | CTD | PMID:25943029 |
Atg5 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATG5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ATG5 mRNA | CTD | PMID:28628672 |
Atg5 | Rat | 3-methyladenine | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | 3-methyladenine inhibits the reaction [Alpha-Amanitin results in increased expression of ATG5 protein] more ... | CTD | PMID:18818525 more ... |
Atg5 | Rat | 3-methyladenine | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | 3-methyladenine results in increased expression of ATG5 protein | CTD | PMID:32587277 |
Atg5 | Rat | 3-methyladenine | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | 3-methyladenine results in decreased expression of ATG5 protein | CTD | PMID:29781141 |
Atg5 | Rat | 3-methyladenine | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 3-methyladenine affects the reaction [Dibutyl Phthalate results in increased expression of ATG5 protein] more ... | CTD | PMID:33462182 more ... |
Atg5 | Rat | 3-methyladenine | decreases expression | EXP | | 6480464 | 3-methyladenine results in decreased expression of ATG5 mRNA and 3-methyladenine results in decreased expression of ATG5 protein | CTD | PMID:30611790 |
Atg5 | Rat | 3-methyladenine | multiple interactions | EXP | | 6480464 | 3-methyladenine inhibits the reaction [aristolochic acid I results in increased expression of ATG5 protein] more ... | CTD | PMID:23939141 more ... |
Atg5 | Rat | 4'-epidoxorubicin | decreases expression | EXP | | 6480464 | Epirubicin results in decreased expression of ATG5 protein | CTD | PMID:29505745 |
Atg5 | Rat | 4'-epidoxorubicin | multiple interactions | EXP | | 6480464 | paeonol inhibits the reaction [Epirubicin results in decreased expression of ATG5 protein] and Sirolimus inhibits the reaction [Epirubicin results in decreased expression of ATG5 protein] | CTD | PMID:29505745 |
Atg5 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ATG5 mRNA | CTD | PMID:28628672 |
Atg5 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | bisphenol S results in increased expression of ATG5 mRNA | CTD | PMID:39298647 |
Atg5 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Atg5 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of ATG5 mRNA | CTD | PMID:29741722 |
Atg5 | Rat | 4-hydroxynon-2-enal | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | 4-hydroxy-2-nonenal results in increased expression of ATG5 mRNA | CTD | PMID:35550146 |
Atg5 | Rat | 4-nonylphenol | increases expression | EXP | | 6480464 | 4-nonylphenol results in increased expression of ATG5 mRNA | CTD | PMID:28041982 and PMID:30228064 |
Atg5 | Rat | 4-phenylbutyric acid | multiple interactions | EXP | | 6480464 | 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of ATG5 mRNA] and 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of ATG5 protein] | CTD | PMID:37654027 |
Atg5 | Rat | 4-phenylbutyric acid | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 mRNA] and 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 protein] | CTD | PMID:34175825 |
Atg5 | Rat | 5-aza-2'-deoxycytidine | decreases expression | EXP | | 6480464 | Decitabine results in decreased expression of ATG5 protein | CTD | PMID:34536542 |
Atg5 | Rat | acrolein | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATG5 mRNA more ... | CTD | PMID:30205151 more ... |
Atg5 | Rat | acrolein | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Acrolein results in increased expression of ATG5 protein | CTD | PMID:30205151 |
Atg5 | Rat | acrylamide | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Acrylamide results in increased expression of ATG5 mRNA | CTD | PMID:34569336 |
Atg5 | Rat | acrylamide | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of ATG5 mRNA | CTD | PMID:32763439 |
Atg5 | Rat | Aescin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG5 protein] | CTD | PMID:36905866 |
Atg5 | Rat | Aescin | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein affects the reaction [Escin inhibits the reaction [Dietary Fats results in decreased expression of ACOX1 mRNA]] more ... | CTD | PMID:36905866 |
Atg5 | Rat | Aescin | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Escin results in increased expression of ATG5 protein | CTD | PMID:36905866 |
Atg5 | Rat | aflatoxin B1 | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of ATG5 mRNA | CTD | PMID:21641981 |
Atg5 | Rat | AICA ribonucleotide | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | AICA ribonucleotide inhibits the reaction [Ethanol results in decreased expression of ATG5 protein] | CTD | PMID:24582693 |
Atg5 | Rat | aldehydo-D-glucose | multiple interactions | EXP | | 6480464 | 3-methyladenine inhibits the reaction [N-(1 more ... | CTD | PMID:29128638 and PMID:38444079 |
Atg5 | Rat | aldehydo-D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of ATG5 mRNA | CTD | PMID:38444079 |
Atg5 | Rat | aldehydo-D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of ATG5 protein | CTD | PMID:29128638 |
Atg5 | Rat | all-trans-retinoic acid | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ATG5 mRNA and Tretinoin results in increased expression of ATG5 protein | CTD | PMID:29743969 |
Atg5 | Rat | all-trans-retinoic acid | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the reaction [Tretinoin results in increased metabolism of and affects the localization of MAP1LC3B protein] more ... | CTD | PMID:28978663 and PMID:29743969 |
Atg5 | Rat | alpha,alpha-trehalose | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Trehalose results in increased expression of ATG5 mRNA | CTD | PMID:23851366 |
Atg5 | Rat | alpha-amanitin | increases expression | EXP | | 6480464 | Alpha-Amanitin results in increased expression of ATG5 protein | CTD | PMID:37329965 |
Atg5 | Rat | alpha-amanitin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | 3-methyladenine inhibits the reaction [Alpha-Amanitin results in increased expression of ATG5 protein] | CTD | PMID:37329965 |
Atg5 | Rat | alpha-D-galactose | multiple interactions | EXP | | 6480464 | candesartan inhibits the reaction [Galactose results in decreased expression of ATG5 mRNA] | CTD | PMID:34906534 |
Atg5 | Rat | alpha-D-galactose | decreases expression | EXP | | 6480464 | Galactose results in decreased expression of ATG5 mRNA | CTD | PMID:34906534 |
Atg5 | Rat | alpha-pinene | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATG5 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATG5 mRNA | CTD | PMID:32699268 |
Atg5 | Rat | Alpinetin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[alpinetin co-treated with TNF protein] results in increased expression of ATG5 mRNA] more ... | CTD | PMID:31676321 |
Atg5 | Rat | Alpinetin | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]] more ... | CTD | PMID:31676321 |
Atg5 | Rat | amiodarone | affects response to substance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the susceptibility to Amiodarone | CTD | PMID:32651653 |
Atg5 | Rat | antirheumatic drug | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of ATG5 mRNA | CTD | PMID:24449571 |
Atg5 | Rat | aristolochic acid A | multiple interactions | EXP | | 6480464 | 3-methyladenine inhibits the reaction [aristolochic acid I results in increased expression of ATG5 protein] and ATG5 affects the reaction [aristolochic acid I results in increased cleavage of PARP1 protein] | CTD | PMID:23939141 |
Atg5 | Rat | aristolochic acid A | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ATG5 mRNA | CTD | PMID:33212167 |
Atg5 | Rat | aristolochic acid A | increases response to substance | EXP | | 6480464 | ATG5 results in increased susceptibility to aristolochic acid I | CTD | PMID:23939141 |
Atg5 | Rat | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of ATG5 protein | CTD | PMID:23939141 |
Atg5 | Rat | arsenite(3-) | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | arsenite results in increased expression of ATG5 mRNA and arsenite results in increased expression of ATG5 protein | CTD | PMID:34929507 |
Atg5 | Rat | arsenous acid | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of ATG5 mRNA and Arsenic Trioxide results in increased expression of ATG5 protein | CTD | PMID:21594580 more ... |
Atg5 | Rat | arsenous acid | multiple interactions | EXP | | 6480464 | ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of ATG5 protein] | CTD | PMID:35195477 |
Atg5 | Rat | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of ATG5 protein | CTD | PMID:35195477 |
Atg5 | Rat | arsenous acid | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] and Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] | CTD | PMID:33462182 |
Atg5 | Rat | arsenous acid | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of ATG5 mRNA | CTD | PMID:30032600 more ... |
Atg5 | Rat | arsenous acid | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] more ... | CTD | PMID:28978663 more ... |
Atg5 | Rat | artesunate | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Artesunate results in increased expression of ATG5 mRNA | CTD | PMID:30551460 |
Atg5 | Rat | atorvastatin calcium | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 mutant form promotes the reaction [Atorvastatin results in increased cleavage of CASP3 protein] and ATG5 mutant form promotes the reaction [Atorvastatin results in increased cleavage of PARP1 protein] | CTD | PMID:20876807 |
Atg5 | Rat | atorvastatin calcium | increases response to substance | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 results in increased susceptibility to Atorvastatin | CTD | PMID:20876807 |
Atg5 | Rat | atrazine | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Atrazine results in increased expression of ATG5 mRNA and Atrazine results in increased expression of ATG5 protein | CTD | PMID:33485040 |
Atg5 | Rat | atrazine | decreases expression | ISO | Atg5 (Mus musculus) | 6480464 | Atrazine results in decreased expression of ATG5 mRNA | CTD | PMID:30360616 |
Atg5 | Rat | atrazine | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | Lycopene inhibits the reaction [Atrazine results in decreased expression of ATG5 mRNA] | CTD | PMID:30360616 |
Atg5 | Rat | bafilomycin A1 | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the reaction [bafilomycin A1 promotes the reaction [gossypol acetic acid results in increased expression of MAP1LC3B protein modified form]] | CTD | PMID:29938581 |
Atg5 | Rat | bafilomycin A1 | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [bafilomycin A1 co-treated with Swainsonine] results in increased expression of ATG5 mRNA and [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of ATG5 protein | CTD | PMID:36402259 |
Atg5 | Rat | benzo[a]pyrene | increases methylation | ISO | ATG5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ATG5 promoter | CTD | PMID:27901495 |
Atg5 | Rat | benzo[a]pyrene | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of ATG5 mRNA and Benzo(a)pyrene results in increased expression of ATG5 protein | CTD | PMID:39454710 |
Atg5 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20018196 |
Atg5 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of ATG5 mRNA | CTD | PMID:34863575 |
Atg5 | Rat | bisphenol A | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of ATG5 mRNA | CTD | PMID:20678512 |
Atg5 | Rat | bisphenol A | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | bisphenol A results in increased expression of ATG5 mRNA | CTD | PMID:34281243 |
Atg5 | Rat | bisphenol A | decreases expression | ISO | Atg5 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of ATG5 mRNA | CTD | PMID:29741722 |
Atg5 | Rat | bisphenol A | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATG5 mRNA | CTD | PMID:28628672 |
Atg5 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ATG5 mRNA | CTD | PMID:27539358 and PMID:30228064 |
Atg5 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ATG5 mRNA | CTD | PMID:25181051 |
Atg5 | Rat | bortezomib | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 gene mutant form inhibits the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP3 protein] and ATG5 gene mutant form inhibits the reaction [HRAS protein promotes the reaction [Bortezomib results in increased cleavage of and results in increased activity of CASP3 protein]] | CTD | PMID:22842577 |
Atg5 | Rat | buprofezin | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | buprofezin results in increased expression of ATG5 mRNA | CTD | PMID:36287832 |
Atg5 | Rat | butachlor | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | butachlor results in increased expression of ATG5 protein | CTD | PMID:34351278 |
Atg5 | Rat | butachlor | decreases expression | ISO | Atg5 (Mus musculus) | 6480464 | butachlor results in decreased expression of ATG5 mRNA | CTD | PMID:34351278 |
Atg5 | Rat | butyric acid | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Butyric Acid results in increased expression of ATG5 protein | CTD | PMID:28600122 |
Atg5 | Rat | butyric acid | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Butyric Acid results in increased expression of ATG5 protein] | CTD | PMID:28600122 |
Atg5 | Rat | cadmium acetate | increases expression | EXP | | 6480464 | cadmium acetate results in increased expression of ATG5 protein | CTD | PMID:29870746 |
Atg5 | Rat | cadmium acetate | multiple interactions | EXP | | 6480464 | [Sirolimus co-treated with cadmium acetate] results in increased expression of ATG5 mRNA and Chloroquine inhibits the reaction [cadmium acetate results in increased expression of ATG5 protein] | CTD | PMID:29870746 |
Atg5 | Rat | cadmium atom | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Cadmium results in increased expression of ATG5 mRNA and Cadmium results in increased expression of ATG5 protein | CTD | PMID:27492225 and PMID:37148155 |
Atg5 | Rat | cadmium atom | affects response to substance | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein affects the susceptibility to Cadmium | CTD | PMID:37506864 |
Atg5 | Rat | cadmium atom | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SQSTM1 protein] and ATG5 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTOR protein] | CTD | PMID:36336208 |
Atg5 | Rat | cadmium atom | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG5 protein more ... | CTD | PMID:29111403 more ... |
Atg5 | Rat | cadmium atom | multiple interactions | EXP | | 6480464 | ATG5 protein affects the reaction [Cadmium results in decreased expression of SQSTM1 protein] more ... | CTD | PMID:27658547 |
Atg5 | Rat | cadmium dichloride | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG5 protein | CTD | PMID:31862506 |
Atg5 | Rat | cadmium dichloride | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SQSTM1 protein] and ATG5 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTOR protein] | CTD | PMID:36336208 |
Atg5 | Rat | cadmium dichloride | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of ATG5 protein | CTD | PMID:33127495 |
Atg5 | Rat | calcitriol | increases response to substance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 results in increased susceptibility to Calcitriol | CTD | PMID:19748465 |
Atg5 | Rat | calcitriol | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased activity of ATG5 mRNA] more ... | CTD | PMID:19748465 |
Atg5 | Rat | calcitriol | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of ATG5 mRNA | CTD | PMID:19748465 |
Atg5 | Rat | camptothecin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 mutant form inhibits the reaction [Camptothecin results in increased degradation of SQSTM1 protein] | CTD | PMID:22927544 |
Atg5 | Rat | candesartan | multiple interactions | EXP | | 6480464 | candesartan inhibits the reaction [Galactose results in decreased expression of ATG5 mRNA] | CTD | PMID:34906534 |
Atg5 | Rat | capsaicin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of and results in increased activity of ATM protein] and ATG5 mutant form inhibits the reaction [Capsaicin results in increased phosphorylation of PRKDC protein] | CTD | PMID:22226932 |
Atg5 | Rat | capsaicin | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Capsaicin results in increased expression of ATG5 protein | CTD | PMID:22226932 |
Atg5 | Rat | carbamazepine | multiple interactions | EXP | | 6480464 | [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of ATG5 mRNA and [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of ATG5 mRNA | CTD | PMID:35786680 |
Atg5 | Rat | carbon disulfide | decreases expression | ISO | Atg5 (Mus musculus) | 6480464 | Carbon Disulfide results in decreased expression of ATG5 mRNA and Carbon Disulfide results in decreased expression of ATG5 protein | CTD | PMID:31369747 |
Atg5 | Rat | carbon disulfide | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of ATG5 mRNA] | CTD | PMID:31369747 |
Atg5 | Rat | carbon nanotube | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of ATG5 protein | CTD | PMID:24929217 |
Atg5 | Rat | carbon nanotube | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the reaction [Nanotubes more ... | CTD | PMID:39033796 |
Atg5 | Rat | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes and Carbon results in increased expression of ATG5 mRNA | CTD | PMID:32951350 |
Atg5 | Rat | carglumic acid | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of ATG5 mRNA] | CTD | PMID:31369747 |
Atg5 | Rat | CGP 52608 | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ATG5 gene] | CTD | PMID:28238834 |
Atg5 | Rat | chloroquine | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | Chloroquine inhibits the reaction [hydroxyethyl methacrylate results in increased expression of ATG5 protein] and Chloroquine promotes the reaction [Arsenic Trioxide results in increased expression of ATG5 protein] | CTD | PMID:28184909 and PMID:30338810 |
Atg5 | Rat | chloroquine | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Chloroquine results in increased expression of ATG5 protein | CTD | PMID:30338810 |
Atg5 | Rat | chloroquine | multiple interactions | EXP | | 6480464 | Chloroquine inhibits the reaction [cadmium acetate results in increased expression of ATG5 protein] | CTD | PMID:29870746 |
Atg5 | Rat | chromium(6+) | multiple interactions | EXP | | 6480464 | [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ATG5 protein | CTD | PMID:36849043 |
Atg5 | Rat | cisplatin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [Cisplatin co-treated with acetyl-11-ketoboswellic acid] results in decreased expression of ATG5 protein more ... | CTD | PMID:21743489 more ... |
Atg5 | Rat | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of ATG5 protein | CTD | PMID:25598344 |
Atg5 | Rat | cisplatin | multiple interactions | EXP | | 6480464 | saponin Rb1 and Panax notoginsenoside promotes the reaction [Cisplatin results in increased expression of ATG5 protein] | CTD | PMID:25598344 |
Atg5 | Rat | cisplatin | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | Oleanolic Acid inhibits the reaction [Cisplatin results in increased expression of ATG5 protein] | CTD | PMID:31306688 |
Atg5 | Rat | cisplatin | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Cisplatin results in increased expression of ATG5 protein | CTD | PMID:31306688 |
Atg5 | Rat | cisplatin | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of ATG5 protein | CTD | PMID:28408137 |
Atg5 | Rat | cisplatin | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ATG5 protein | CTD | PMID:24817946 |
Atg5 | Rat | cisplatin | decreases response to substance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein results in decreased susceptibility to Cisplatin | CTD | PMID:21351258 |
Atg5 | Rat | colistin | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Colistin results in increased expression of ATG5 mRNA | CTD | PMID:35378205 |
Atg5 | Rat | copper atom | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 mRNA and [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 protein | CTD | PMID:31491480 |
Atg5 | Rat | copper(0) | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 mRNA and [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 protein | CTD | PMID:31491480 |
Atg5 | Rat | copper(II) sulfate | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 mRNA and [Copper Sulfate results in increased abundance of Copper] which results in increased expression of ATG5 protein | CTD | PMID:31491480 |
Atg5 | Rat | cordycepin | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | cordycepin results in increased expression of ATG5 mRNA | CTD | PMID:36881089 |
Atg5 | Rat | crocin-1 | multiple interactions | EXP | | 6480464 | crocin inhibits the reaction [Blood Glucose results in increased expression of ATG5 protein] more ... | CTD | PMID:33021114 |
Atg5 | Rat | curcumin | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Curcumin results in decreased expression of ATG5 protein | CTD | PMID:36640941 |
Atg5 | Rat | curcumin | decreases expression | ISO | Atg5 (Mus musculus) | 6480464 | Curcumin results in decreased expression of ATG5 protein | CTD | PMID:36640941 |
Atg5 | Rat | curcumin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | Curcumin inhibits the reaction [Tunicamycin results in increased expression of ATG5 protein] | CTD | PMID:36640941 |
Atg5 | Rat | Curcumol | multiple interactions | EXP | | 6480464 | [ATG5 protein co-treated with curcumol] inhibits the reaction [VEGFA protein results in increased expression of ANGPT2 protein] more ... | CTD | PMID:33549628 |
Atg5 | Rat | Curcumol | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein inhibits the reaction [curcumol inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein]] more ... | CTD | PMID:33549628 |
Atg5 | Rat | cyclophosphamide | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | Fungal Polysaccharides inhibits the reaction [Cyclophosphamide results in decreased expression of ATG5 protein] and Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of ATG5 protein] | CTD | PMID:32151603 |
Atg5 | Rat | cyclophosphamide | decreases expression | ISO | Atg5 (Mus musculus) | 6480464 | Cyclophosphamide results in decreased expression of ATG5 protein | CTD | PMID:32151603 |
Atg5 | Rat | cyclosporin A | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ATG5 mRNA | CTD | PMID:25562108 |
Atg5 | Rat | cypermethrin | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | cypermethrin results in increased expression of ATG5 mRNA | CTD | PMID:27704156 |
Atg5 | Rat | D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of ATG5 protein | CTD | PMID:29128638 |
Atg5 | Rat | D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of ATG5 mRNA | CTD | PMID:38444079 |
Atg5 | Rat | D-glucose | multiple interactions | EXP | | 6480464 | 3-methyladenine inhibits the reaction [N-(1 more ... | CTD | PMID:29128638 and PMID:38444079 |
Atg5 | Rat | dapagliflozin | multiple interactions | EXP | | 6480464 | dapagliflozin inhibits the reaction [Doxorubicin results in increased expression of ATG5 mRNA] | CTD | PMID:38997059 |
Atg5 | Rat | deoxynivalenol | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | deoxynivalenol results in increased expression of ATG5 mRNA and deoxynivalenol results in increased expression of ATG5 protein | CTD | PMID:35381244 |
Atg5 | Rat | deoxynivalenol | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]] more ... | CTD | PMID:35381244 |
Atg5 | Rat | dexamethasone | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATG5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ATG5 mRNA | CTD | PMID:28628672 |
Atg5 | Rat | dextran sulfate | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]] more ... | CTD | PMID:27611972 more ... |
Atg5 | Rat | dextran sulfate | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Dextran Sulfate results in increased expression of ATG5 mRNA | CTD | PMID:31676321 |
Atg5 | Rat | diarsenic trioxide | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of ATG5 mRNA and Arsenic Trioxide results in increased expression of ATG5 protein | CTD | PMID:21594580 more ... |
Atg5 | Rat | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of ATG5 protein | CTD | PMID:35195477 |
Atg5 | Rat | diarsenic trioxide | multiple interactions | EXP | | 6480464 | ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of ATG5 protein] | CTD | PMID:35195477 |
Atg5 | Rat | diarsenic trioxide | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] and Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] | CTD | PMID:33462182 |
Atg5 | Rat | diarsenic trioxide | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of ATG5 mRNA | CTD | PMID:30032600 more ... |
Atg5 | Rat | diarsenic trioxide | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] more ... | CTD | PMID:28978663 more ... |
Atg5 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of ATG5 mRNA | CTD | PMID:30053495 |
Atg5 | Rat | dibutyl phthalate | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of ATG5 protein | CTD | PMID:37277016 |
Atg5 | Rat | dibutyl phthalate | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 3-methyladenine affects the reaction [Dibutyl Phthalate results in increased expression of ATG5 protein] | CTD | PMID:37277016 |
Atg5 | Rat | dicrotophos | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of ATG5 mRNA | CTD | PMID:28302478 |
Atg5 | Rat | dieldrin | affects methylation | ISO | Atg5 (Mus musculus) | 6480464 | Dieldrin affects the methylation of ATG5 gene | CTD | PMID:38995845 |
Atg5 | Rat | diisononyl phthalate | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | diisononyl phthalate results in increased expression of ATG5 protein | CTD | PMID:37976928 |
Atg5 | Rat | diisononyl phthalate | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATF4 protein promotes the reaction [diisononyl phthalate results in increased expression of ATG5 protein] and DDIT4 protein promotes the reaction [diisononyl phthalate results in increased expression of ATG5 protein] | CTD | PMID:37976928 |
Atg5 | Rat | dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of ATG5 mRNA | CTD | PMID:28983604 |
Atg5 | Rat | dioxygen | multiple interactions | EXP | | 6480464 | sanggenone C inhibits the reaction [Oxygen deficiency results in decreased expression of ATG5 mRNA] | CTD | PMID:28983604 |
Atg5 | Rat | diphenhydramine | affects response to substance | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein affects the susceptibility to Diphenhydramine | CTD | PMID:22310178 |
Atg5 | Rat | diquat | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Diquat results in increased expression of ATG5 protein | CTD | PMID:38128689 |
Atg5 | Rat | disodium selenite | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of ATG5 protein | CTD | PMID:25204997 |
Atg5 | Rat | Doramectin | increases expression | EXP | | 6480464 | doramectin results in increased expression of ATG5 protein | CTD | PMID:35137919 |
Atg5 | Rat | Doramectin | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | doramectin results in increased expression of ATG5 protein | CTD | PMID:35137919 |
Atg5 | Rat | doxorubicin | multiple interactions | EXP | | 6480464 | [4-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amino)methyl)benzoic acid co-treated with Doxorubicin] results in increased expression of ATG5 protein more ... | CTD | PMID:32652078 more ... |
Atg5 | Rat | doxorubicin | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Doxorubicin results in increased expression of ATG5 protein | CTD | PMID:36639017 |
Atg5 | Rat | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of ATG5 mRNA and Doxorubicin results in increased expression of ATG5 protein | CTD | PMID:36639017 and PMID:38997059 |
Atg5 | Rat | doxorubicin | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | OTUD7B protein inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein] and Sirolimus inhibits the reaction [OTUD7B protein inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein]] | CTD | PMID:36639017 |
Atg5 | Rat | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ATG5 mRNA | CTD | PMID:34933056 |
Atg5 | Rat | doxorubicin | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ATG5 mRNA | CTD | PMID:29803840 |
Atg5 | Rat | doxorubicin | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of ATG5 protein | CTD | PMID:31226464 |
Atg5 | Rat | doxorubicin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | PQQ Cofactor inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein] | CTD | PMID:31226464 |
Atg5 | Rat | ellagic acid | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Ellagic Acid results in increased expression of ATG5 mRNA | CTD | PMID:12002526 |
Atg5 | Rat | embelin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | embelin results in increased cleavage of [ATG12 protein binds to ATG5 protein] | CTD | PMID:28722333 |
Atg5 | Rat | erastin | increases expression | EXP | | 6480464 | erastin results in increased expression of ATG5 protein | CTD | PMID:32937103 |
Atg5 | Rat | erlotinib hydrochloride | decreases response to substance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein results in decreased susceptibility to Erlotinib Hydrochloride | CTD | PMID:23917044 |
Atg5 | Rat | erlotinib hydrochloride | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Erlotinib Hydrochloride results in increased expression of ATG5 protein | CTD | PMID:21655094 |
Atg5 | Rat | ethanol | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | NR1H4 gene mutant form inhibits the reaction [Ethanol results in increased expression of ATG5 mRNA] more ... | CTD | PMID:24095927 more ... |
Atg5 | Rat | ethanol | decreases expression | ISO | Atg5 (Mus musculus) | 6480464 | Ethanol results in decreased expression of ATG5 protein | CTD | PMID:34405320 |
Atg5 | Rat | ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of ATG5 protein | CTD | PMID:24582693 |
Atg5 | Rat | ethanol | multiple interactions | EXP | | 6480464 | ADIPOQ protein inhibits the reaction [Ethanol results in decreased expression of ATG5 protein] | CTD | PMID:24582693 |
Atg5 | Rat | ethanol | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Ethanol results in decreased expression of ATG5 mRNA and Ethanol results in decreased expression of ATG5 protein | CTD | PMID:24582693 and PMID:34405320 |
Atg5 | Rat | ethanol | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ADIPOQ protein inhibits the reaction [Ethanol results in decreased expression of ATG5 mRNA] more ... | CTD | PMID:24582693 and PMID:34405320 |
Atg5 | Rat | ethanol | decreases response to substance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein results in decreased susceptibility to Ethanol | CTD | PMID:24582693 |
Atg5 | Rat | ethanol | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Ethanol results in increased expression of ATG5 mRNA and Ethanol results in increased expression of ATG5 protein | CTD | PMID:24095927 more ... |
Atg5 | Rat | ethanol | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Ethanol results in increased expression of ATG5 mRNA | CTD | PMID:24095927 |
Atg5 | Rat | ferric oxide | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | ferric oxide analog results in increased expression of ATG5 protein | CTD | PMID:24068039 |
Atg5 | Rat | ferrostatin-1 | multiple interactions | EXP | | 6480464 | ferrostatin-1 inhibits the reaction [Arsenic Trioxide results in decreased expression of ATG5 protein] | CTD | PMID:35195477 |
Atg5 | Rat | fingolimod hydrochloride | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Fingolimod Hydrochloride results in increased expression of ATG5 protein | CTD | PMID:25939952 |
Atg5 | Rat | flavokawain B | affects response to substance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the susceptibility to flavokawain B | CTD | PMID:30025493 |
Atg5 | Rat | flavokawain B | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [ATG5 protein affects the susceptibility to flavokawain B] which affects the cleavage of CASP3 protein more ... | CTD | PMID:30025493 |
Atg5 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of ATG5 mRNA | CTD | PMID:24136188 |
Atg5 | Rat | folic acid | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATG5 mRNA | CTD | PMID:22206623 |
Atg5 | Rat | Fusaric acid | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Fusaric Acid results in increased expression of ATG5 mRNA | CTD | PMID:30582969 |
Atg5 | Rat | galactose | multiple interactions | EXP | | 6480464 | candesartan inhibits the reaction [Galactose results in decreased expression of ATG5 mRNA] | CTD | PMID:34906534 |
Atg5 | Rat | galactose | decreases expression | EXP | | 6480464 | Galactose results in decreased expression of ATG5 mRNA | CTD | PMID:34906534 |
Atg5 | Rat | gefitinib | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | gefitinib results in increased expression of ATG5 protein | CTD | PMID:21655094 |
Atg5 | Rat | genistein | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Genistein results in increased expression of ATG5 mRNA | CTD | PMID:15256057 |
Atg5 | Rat | geraniol | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | geraniol inhibits the reaction [Rotenone results in decreased expression of ATG5 protein] | CTD | PMID:30141137 |
Atg5 | Rat | glucose | multiple interactions | EXP | | 6480464 | 3-methyladenine inhibits the reaction [N-(1 more ... | CTD | PMID:29128638 and PMID:38444079 |
Atg5 | Rat | glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of ATG5 mRNA | CTD | PMID:38444079 |
Atg5 | Rat | glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of ATG5 protein | CTD | PMID:29128638 |
Atg5 | Rat | glutathione | affects abundance | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein affects the abundance of Glutathione | CTD | PMID:22491424 |
Atg5 | Rat | glutathione | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [ATG5 gene mutant form results in increased activity of NFE2L2 protein] affects the reaction [Acetaminophen affects the abundance of Glutathione] more ... | CTD | PMID:22491424 |
Atg5 | Rat | glycochenodeoxycholic acid | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | TFE3 protein inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of ATG5 mRNA] | CTD | PMID:32439580 |
Atg5 | Rat | glycochenodeoxycholic acid | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Glycochenodeoxycholic Acid results in decreased expression of ATG5 mRNA and Glycochenodeoxycholic Acid results in decreased expression of ATG5 protein | CTD | PMID:32439580 |
Atg5 | Rat | glyphosate | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Glyphosate results in increased expression of ATG5 mRNA | CTD | PMID:31874349 |
Atg5 | Rat | gossypetin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | gossypetin promotes the reaction [malondialdehyde-low density lipoprotein and human promotes the reaction [ATG5 protein binds to ATG12 protein]] | CTD | PMID:25622137 |
Atg5 | Rat | hesperetin | multiple interactions | EXP | | 6480464 | hesperetin inhibits the reaction [Doxorubicin results in decreased expression of ATG5 mRNA] | CTD | PMID:34933056 |
Atg5 | Rat | hexadecanoic acid | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG5 protein more ... | CTD | PMID:25943029 and PMID:36905866 |
Atg5 | Rat | hexadecanoic acid | multiple interactions | EXP | | 6480464 | ATG5 protein promotes the reaction [C1QTNF9 protein inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]] | CTD | PMID:32278738 |
Atg5 | Rat | HU-308 | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]] and ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]] | CTD | PMID:27611972 |
Atg5 | Rat | hyaluronic acid | multiple interactions | EXP | | 6480464 | roxadustat promotes the reaction [Hyaluronic Acid results in increased cleavage of ATG5 protein] | CTD | PMID:27082295 |
Atg5 | Rat | hyaluronic acid | increases cleavage | EXP | | 6480464 | Hyaluronic Acid results in increased cleavage of ATG5 protein | CTD | PMID:27082295 |
Atg5 | Rat | hydroquinone | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | PARP1 protein promotes the reaction [hydroquinone results in increased expression of ATG5 mRNA] and SIRT1 protein inhibits the reaction [hydroquinone results in increased expression of ATG5 mRNA] | CTD | PMID:28263894 |
Atg5 | Rat | hydroquinone | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | hydroquinone results in increased expression of ATG5 mRNA | CTD | PMID:28263894 |
Atg5 | Rat | indometacin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ATG5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ATG5 mRNA | CTD | PMID:28628672 |
Atg5 | Rat | ivermectin | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of ATG5 protein | CTD | PMID:32959892 |
Atg5 | Rat | JTE-013 | multiple interactions | EXP | | 6480464 | JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased expression of ATG5 protein] | CTD | PMID:37169277 |
Atg5 | Rat | kainic acid | multiple interactions | EXP | | 6480464 | NADP inhibits the reaction [Kainic Acid results in increased expression of ATG5 protein] | CTD | PMID:32057834 |
Atg5 | Rat | kainic acid | increases expression | EXP | | 6480464 | Kainic Acid results in increased expression of ATG5 protein | CTD | PMID:32057834 |
Atg5 | Rat | L-leucine | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]] | CTD | PMID:31676321 |
Atg5 | Rat | lead diacetate | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 mRNA | CTD | PMID:33445541 |
Atg5 | Rat | lead diacetate | multiple interactions | EXP | | 6480464 | [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 mRNA and [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 protein | CTD | PMID:36652739 |
Atg5 | Rat | lead(0) | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 mRNA | CTD | PMID:33445541 |
Atg5 | Rat | lead(0) | multiple interactions | EXP | | 6480464 | [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 mRNA and [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 protein | CTD | PMID:36652739 |
Atg5 | Rat | levamisole | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of ATG5 protein] | CTD | PMID:32151603 |
Atg5 | Rat | lipopolysaccharide | increases cleavage | EXP | | 6480464 | Lipopolysaccharides results in increased cleavage of ATG5 protein | CTD | PMID:24973090 |
Atg5 | Rat | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of ATG5 mRNA and Lipopolysaccharides results in increased expression of ATG5 protein | CTD | PMID:37654027 |
Atg5 | Rat | lipopolysaccharide | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]] more ... | CTD | PMID:27611972 and PMID:30301768 |
Atg5 | Rat | lipopolysaccharide | affects response to substance | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein affects the susceptibility to Lipopolysaccharides | CTD | PMID:30301768 |
Atg5 | Rat | lipopolysaccharide | multiple interactions | EXP | | 6480464 | 3-methyladenine promotes the reaction [Lipopolysaccharides results in increased expression of ATG5 protein] more ... | CTD | PMID:24973090 and PMID:37654027 |
Atg5 | Rat | luteolin | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Luteolin results in increased expression of ATG5 protein | CTD | PMID:32268164 |
Atg5 | Rat | luteolin | multiple interactions | EXP | | 6480464 | Luteolin inhibits the reaction [Methamphetamine results in increased expression of ATG5 protein] | CTD | PMID:32035215 |
Atg5 | Rat | LY294002 | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA]] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA] | CTD | PMID:35568058 |
Atg5 | Rat | lycopene | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | Lycopene inhibits the reaction [Atrazine results in decreased expression of ATG5 mRNA] | CTD | PMID:30360616 |
Atg5 | Rat | lycopene | multiple interactions | EXP | | 6480464 | [Glucose co-treated with Lycopene] results in increased expression of ATG5 mRNA | CTD | PMID:38444079 |
Atg5 | Rat | melatonin | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA]] and Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA] | CTD | PMID:35568058 |
Atg5 | Rat | menadione | affects response to substance | EXP | | 6480464 | ATG5 mRNA affects the susceptibility to Vitamin K 3 | CTD | PMID:20578144 |
Atg5 | Rat | menadione | affects response to substance | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein affects the susceptibility to Vitamin K 3 | CTD | PMID:18073215 and PMID:18319638 |
Atg5 | Rat | metformin | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [Blood Glucose results in increased expression of ATG5 protein] | CTD | PMID:33021114 |
Atg5 | Rat | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of ATG5 mRNA and Methamphetamine results in increased expression of ATG5 protein | CTD | PMID:32035215 more ... |
Atg5 | Rat | methamphetamine | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of ATG5 protein | CTD | PMID:33359793 |
Atg5 | Rat | methamphetamine | multiple interactions | EXP | | 6480464 | Luteolin inhibits the reaction [Methamphetamine results in increased expression of ATG5 protein] | CTD | PMID:32035215 |
Atg5 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of ATG5 gene | CTD | PMID:35440735 |
Atg5 | Rat | methylisothiazolinone | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of ATG5 protein | CTD | PMID:29110394 |
Atg5 | Rat | methylmercury chloride | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of ATG5 mRNA | CTD | PMID:23179753 and PMID:27188386 |
Atg5 | Rat | methylmercury chloride | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 promotes the reaction [methylmercuric chloride results in increased cleavage of CASP3 protein] more ... | CTD | PMID:27667695 |
Atg5 | Rat | methylmercury chloride | affects response to substance | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 affects the susceptibility to methylmercuric chloride | CTD | PMID:27667695 |
Atg5 | Rat | methylphenidate | increases expression | EXP | | 6480464 | Methylphenidate results in increased expression of ATG5 mRNA | CTD | PMID:32746681 |
Atg5 | Rat | microcystin-LR | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | cyanoginosin LR results in increased expression of ATG5 mRNA and cyanoginosin LR results in increased expression of ATG5 protein | CTD | PMID:34175825 |
Atg5 | Rat | microcystin-LR | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 mRNA] and 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG5 protein] | CTD | PMID:34175825 |
Atg5 | Rat | mitoxantrone | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Mitoxantrone results in decreased expression of ATG5 protein | CTD | PMID:36216988 |
Atg5 | Rat | MJN110 | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein affects the reaction [MJN110 affects the reaction [Lipopolysaccharides affects the secretion of CCL2 protein]] more ... | CTD | PMID:30301768 |
Atg5 | Rat | N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide | multiple interactions | EXP | | 6480464 | 3-methyladenine inhibits the reaction [N-(1 more ... | CTD | PMID:29128638 |
Atg5 | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG5 protein] more ... | CTD | PMID:20543569 more ... |
Atg5 | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG5 mRNA] and Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG5 mRNA] | CTD | PMID:24614525 and PMID:33462182 |
Atg5 | Rat | N-methyl-4-phenylpyridinium | affects response to substance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the susceptibility to 1-Methyl-4-phenylpyridinium | CTD | PMID:23997112 |
Atg5 | Rat | N-methyl-4-phenylpyridinium | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased cleavage of and results in increased activity of CASP3 protein] | CTD | PMID:23997112 |
Atg5 | Rat | NADP zwitterion | multiple interactions | EXP | | 6480464 | NADP inhibits the reaction [Kainic Acid results in increased expression of ATG5 protein] | CTD | PMID:32057834 |
Atg5 | Rat | NADP(+) | multiple interactions | EXP | | 6480464 | NADP inhibits the reaction [Kainic Acid results in increased expression of ATG5 protein] | CTD | PMID:32057834 |
Atg5 | Rat | nickel atom | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [Nickel co-treated with austenitic steel analog] results in increased expression of ATG5 mRNA | CTD | PMID:23638002 |
Atg5 | Rat | nickel atom | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA]] more ... | CTD | PMID:35568058 |
Atg5 | Rat | nickel atom | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Nickel results in increased expression of ATG5 mRNA | CTD | PMID:25583101 |
Atg5 | Rat | nickel dichloride | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG5 mRNA]] more ... | CTD | PMID:35568058 |
Atg5 | Rat | Nonidet P-40 | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Nonidet P-40 results in decreased expression of ATG5 mRNA | CTD | PMID:26552463 |
Atg5 | Rat | obeticholic acid | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in decreased expression of ATG5 mRNA] | CTD | PMID:35439472 |
Atg5 | Rat | oleanolic acid | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | Oleanolic Acid inhibits the reaction [Cisplatin results in increased expression of ATG5 protein] | CTD | PMID:31306688 |
Atg5 | Rat | oleanolic acid | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Oleanolic Acid analog results in increased expression of ATG5 protein and Oleanolic Acid results in increased expression of ATG5 protein | CTD | PMID:26612655 and PMID:35690101 |
Atg5 | Rat | oleic acid | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG5 protein and Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG5 protein] | CTD | PMID:36905866 |
Atg5 | Rat | oligopeptide | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Oligopeptides analog results in increased expression of ATG5 protein | CTD | PMID:24875536 |
Atg5 | Rat | ozone | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATG5 mRNA more ... | CTD | PMID:32699268 and PMID:32845096 |
Atg5 | Rat | p-menthan-3-ol | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Menthol results in increased expression of ATG5 mRNA | CTD | PMID:26760959 |
Atg5 | Rat | Paeonol | multiple interactions | EXP | | 6480464 | paeonol inhibits the reaction [Epirubicin results in decreased expression of ATG5 protein] | CTD | PMID:29505745 |
Atg5 | Rat | paracetamol | affects expression | ISO | Atg5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of ATG5 mRNA | CTD | PMID:17562736 |
Atg5 | Rat | paracetamol | affects response to substance | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein affects the susceptibility to Acetaminophen | CTD | PMID:22491424 |
Atg5 | Rat | paracetamol | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [ATG5 gene mutant form results in increased activity of NFE2L2 protein] affects the reaction [Acetaminophen affects the abundance of Glutathione] more ... | CTD | PMID:22491424 |
Atg5 | Rat | paraquat | affects response to substance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the susceptibility to Paraquat | CTD | PMID:22982048 and PMID:23997112 |
Atg5 | Rat | paraquat | affects response to substance | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein affects the susceptibility to Paraquat | CTD | PMID:22982048 |
Atg5 | Rat | paraquat | affects response to substance | EXP | | 6480464 | ATG5 protein affects the susceptibility to Paraquat | CTD | PMID:27324791 |
Atg5 | Rat | paraquat | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Paraquat results in increased expression of ATG5 mRNA | CTD | PMID:27220436 |
Atg5 | Rat | paraquat | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [ATG5 protein affects the susceptibility to Paraquat] which affects the abundance of Lipofuscin more ... | CTD | PMID:22982048 and PMID:27246695 |
Atg5 | Rat | paraquat | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Paraquat results in increased expression of ATG5 mRNA and Paraquat results in increased expression of ATG5 protein | CTD | PMID:22982048 more ... |
Atg5 | Rat | paraquat | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [ATG5 protein affects the susceptibility to Paraquat] which affects the abundance of Lipofuscin more ... | CTD | PMID:22982048 more ... |
Atg5 | Rat | patulin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the reaction [Patulin results in increased expression of and results in increased cleavage of GSDMD protein] and ATG5 protein affects the reaction [Patulin results in increased expression of IL1B protein] | CTD | PMID:33217525 |
Atg5 | Rat | perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of ATG5 mRNA | CTD | PMID:27825932 |
Atg5 | Rat | perfluorooctanoic acid | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | perfluorooctanoic acid results in increased expression of ATG5 mRNA | CTD | PMID:26879310 |
Atg5 | Rat | perfluorooctanoic acid | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein promotes the reaction [perfluorooctanoic acid results in increased expression of MAP1LC3B protein modified form] | CTD | PMID:26879310 |
Atg5 | Rat | phenobarbital | multiple interactions | EXP | | 6480464 | Phenobarbital inhibits the reaction [Dietary Fats results in increased expression of ATG5 mRNA] | CTD | PMID:36657701 |
Atg5 | Rat | pirinixic acid | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of ATG5 mRNA | CTD | PMID:23811191 |
Atg5 | Rat | potassium chromate | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of ATG5 mRNA | CTD | PMID:22079256 |
Atg5 | Rat | potassium chromate | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATG5 mRNA | CTD | PMID:22079256 |
Atg5 | Rat | potassium dichromate | multiple interactions | EXP | | 6480464 | [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ATG5 protein | CTD | PMID:36849043 |
Atg5 | Rat | promethazine | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Promethazine results in decreased expression of ATG5 protein | CTD | PMID:31682805 |
Atg5 | Rat | propiconazole | decreases expression | ISO | Atg5 (Mus musculus) | 6480464 | propiconazole results in decreased expression of ATG5 mRNA | CTD | PMID:21278054 |
Atg5 | Rat | psoralen | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Ficusin results in increased expression of ATG5 protein | CTD | PMID:39299507 |
Atg5 | Rat | pterostilbene | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein] and SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]] | CTD | PMID:34405320 |
Atg5 | Rat | pterostilbene | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein] and SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]] | CTD | PMID:34405320 |
Atg5 | Rat | pyrroloquinoline quinone | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | PQQ Cofactor inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein] | CTD | PMID:31226464 |
Atg5 | Rat | quercetin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | Quercetin results in increased expression of [ATG12 protein binds to ATG5 protein] | CTD | PMID:25293876 |
Atg5 | Rat | quercetin | multiple interactions | EXP | | 6480464 | crocin promotes the reaction [Quercetin inhibits the reaction [Blood Glucose results in increased expression of ATG5 protein]] more ... | CTD | PMID:33021114 and PMID:34751495 |
Atg5 | Rat | rac-lactic acid | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of ATG5 mRNA | CTD | PMID:30851411 |
Atg5 | Rat | raloxifene | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | Raloxifene Hydrochloride promotes the reaction [ATG12 protein binds to ATG5 protein] | CTD | PMID:25537862 |
Atg5 | Rat | reactive oxygen species | decreases abundance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein results in decreased abundance of Reactive Oxygen Species | CTD | PMID:31926197 |
Atg5 | Rat | resveratrol | affects response to substance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the susceptibility to resveratrol | CTD | PMID:23680031 |
Atg5 | Rat | resveratrol | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | resveratrol results in increased expression of ATG5 mRNA | CTD | PMID:24095927 |
Atg5 | Rat | resveratrol | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | resveratrol promotes the reaction [Ethanol results in increased expression of ATG5 mRNA] | CTD | PMID:24095927 |
Atg5 | Rat | resveratrol | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the reaction [[TNF protein co-treated with Resveratrol] results in increased expression of MAP1LC3B protein alternative form] more ... | CTD | PMID:23680031 more ... |
Atg5 | Rat | resveratrol | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | resveratrol results in increased expression of ATG5 mRNA | CTD | PMID:12002526 more ... |
Atg5 | Rat | rotenone | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the reaction [Sirolimus inhibits the reaction [Rotenone results in increased cleavage of PARP1 protein]] more ... | CTD | PMID:19682553 more ... |
Atg5 | Rat | rotenone | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of ATG5 protein | CTD | PMID:30141137 and PMID:31926197 |
Atg5 | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of ATG5 protein | CTD | PMID:25725130 |
Atg5 | Rat | rotenone | multiple interactions | EXP | | 6480464 | [Particulate Matter co-treated with Rotenone] results in decreased expression of ATG5 protein more ... | CTD | PMID:25725130 and PMID:33823232 |
Atg5 | Rat | rotenone | affects response to substance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the susceptibility to Rotenone | CTD | PMID:18032788 |
Atg5 | Rat | roxadustat | multiple interactions | EXP | | 6480464 | roxadustat promotes the reaction [Hyaluronic Acid results in increased cleavage of ATG5 protein] | CTD | PMID:27082295 |
Atg5 | Rat | ruthenium red | multiple interactions | EXP | | 6480464 | Ruthenium Red inhibits the reaction [Cadmium Compounds results in increased expression of ATG5 protein] | CTD | PMID:34308505 |
Atg5 | Rat | Sanggenon C | multiple interactions | EXP | | 6480464 | sanggenone C inhibits the reaction [Oxygen deficiency results in decreased expression of ATG5 mRNA] | CTD | PMID:28983604 |
Atg5 | Rat | SB 203580 | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | SB 203580 inhibits the reaction [Calcitriol results in increased activity of ATG5 mRNA] | CTD | PMID:19748465 |
Atg5 | Rat | sevoflurane | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Sevoflurane results in increased expression of ATG5 protein | CTD | PMID:35472370 |
Atg5 | Rat | silicon dioxide | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | GAS6 gene mutant form inhibits the reaction [Silicon Dioxide results in increased expression of ATG5 mRNA] more ... | CTD | PMID:33232774 |
Atg5 | Rat | silicon dioxide | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of ATG5 mRNA and Silicon Dioxide results in increased expression of ATG5 protein | CTD | PMID:33232774 |
Atg5 | Rat | sirolimus | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [Sirolimus co-treated with TNF protein] results in increased expression of ATG5 mRNA more ... | CTD | PMID:19682553 more ... |
Atg5 | Rat | sirolimus | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | Sirolimus inhibits the reaction [OTUD7B protein inhibits the reaction [Doxorubicin results in increased expression of ATG5 protein]] | CTD | PMID:36639017 |
Atg5 | Rat | sirolimus | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Sirolimus results in increased expression of ATG5 protein | CTD | PMID:29781141 and PMID:30338810 |
Atg5 | Rat | sirolimus | increases expression | EXP | | 6480464 | Sirolimus results in increased expression of ATG5 mRNA and Sirolimus results in increased expression of ATG5 protein | CTD | PMID:30611790 |
Atg5 | Rat | sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus co-treated with cadmium acetate] results in increased expression of ATG5 mRNA more ... | CTD | PMID:29128638 more ... |
Atg5 | Rat | sodium arsenite | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of ATG5 protein | CTD | PMID:28888487 |
Atg5 | Rat | sodium arsenite | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of ATG5 mRNA and sodium arsenite results in increased expression of ATG5 protein | CTD | PMID:38387523 |
Atg5 | Rat | sodium arsenite | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in increased expression of ATG5 mRNA]] more ... | CTD | PMID:30097599 and PMID:35381244 |
Atg5 | Rat | sodium arsenite | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the reaction [sodium arsenite results in increased activity of PARP1 protein] and ATG5 protein affects the reaction [sodium arsenite results in increased expression of BECN1 protein] | CTD | PMID:28888487 and PMID:36958258 |
Atg5 | Rat | sodium fluoride | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of ATG5 mRNA and Sodium Fluoride results in increased expression of ATG5 protein | CTD | PMID:24296261 |
Atg5 | Rat | sodium fluoride | increases expression | EXP | | 6480464 | Sodium Fluoride results in increased expression of ATG5 mRNA and Sodium Fluoride results in increased expression of ATG5 protein | CTD | PMID:24296261 |
Atg5 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of ATG5 protein | CTD | PMID:31102696 |
Atg5 | Rat | sorafenib | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [Sorafenib co-treated with Vorinostat] promotes the reaction [FAS protein binds to CASP8 protein binds to ATG5 protein binds to HSPA5 protein] more ... | CTD | PMID:18787411 |
Atg5 | Rat | sorafenib | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | sorafenib results in increased expression of ATG5 protein | CTD | PMID:18787411 |
Atg5 | Rat | sphingosine 1-phosphate | increases expression | EXP | | 6480464 | sphingosine 1-phosphate results in increased expression of ATG5 mRNA and sphingosine 1-phosphate results in increased expression of ATG5 protein | CTD | PMID:37169277 |
Atg5 | Rat | sphingosine 1-phosphate | multiple interactions | EXP | | 6480464 | 3-methyladenine inhibits the reaction [sphingosine 1-phosphate results in increased expression of ATG5 protein] more ... | CTD | PMID:37169277 |
Atg5 | Rat | stilbenoid | decreases response to substance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein results in decreased susceptibility to Stilbenes | CTD | PMID:23059970 |
Atg5 | Rat | streptozocin | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Streptozocin results in increased expression of ATG5 mRNA | CTD | PMID:24889822 |
Atg5 | Rat | streptozocin | multiple interactions | EXP | | 6480464 | [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of ATG5 mRNA and [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of ATG5 mRNA | CTD | PMID:35786680 |
Atg5 | Rat | streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of ATG5 protein | CTD | PMID:38706688 |
Atg5 | Rat | swainsonine | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [bafilomycin A1 co-treated with Swainsonine] results in increased expression of ATG5 mRNA and [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of ATG5 protein | CTD | PMID:36402259 |
Atg5 | Rat | swainsonine | increases expression | EXP | | 6480464 | Swainsonine results in increased expression of ATG5 protein | CTD | PMID:37442287 |
Atg5 | Rat | swainsonine | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Swainsonine results in increased expression of ATG5 mRNA and Swainsonine results in increased expression of ATG5 protein | CTD | PMID:36402259 |
Atg5 | Rat | T-2 toxin | affects expression | EXP | | 6480464 | T-2 Toxin affects the expression of ATG5 protein | CTD | PMID:29413859 |
Atg5 | Rat | T-2 toxin | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | T-2 Toxin results in increased expression of ATG5 protein | CTD | PMID:35289972 |
Atg5 | Rat | T-2 toxin | affects expression | ISO | Atg5 (Mus musculus) | 6480464 | T-2 Toxin affects the expression of ATG5 protein | CTD | PMID:36402210 |
Atg5 | Rat | T-2 toxin | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | 3-methyladenine affects the reaction [T-2 Toxin affects the expression of ATG5 protein] | CTD | PMID:36402210 |
Atg5 | Rat | temozolomide | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of ATG5 mRNA | CTD | PMID:31758290 |
Atg5 | Rat | tert-butyl hydroperoxide | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of ATG5 mRNA | CTD | PMID:15336504 |
Atg5 | Rat | tetrachloromethane | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of ATG5 protein more ... | CTD | PMID:31513885 and PMID:33549628 |
Atg5 | Rat | thiacloprid | decreases expression | ISO | Atg5 (Mus musculus) | 6480464 | thiacloprid results in decreased expression of ATG5 mRNA and thiacloprid results in decreased expression of ATG5 protein | CTD | PMID:37468076 |
Atg5 | Rat | thymoquinone | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | thymoquinone results in decreased expression of ATG5 protein | CTD | PMID:31298468 |
Atg5 | Rat | titanium dioxide | decreases methylation | ISO | Atg5 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of ATG5 gene | CTD | PMID:35295148 |
Atg5 | Rat | trans-piceid | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | polydatin inhibits the reaction [Rotenone results in decreased expression of ATG5 protein] | CTD | PMID:31926197 |
Atg5 | Rat | trifluoperazine | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Trifluoperazine results in increased expression of ATG5 protein | CTD | PMID:38360085 |
Atg5 | Rat | Triptolide | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | triptolide results in increased expression of ATG5 protein | CTD | PMID:26990902 |
Atg5 | Rat | trovafloxacin | affects response to substance | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the susceptibility to trovafloxacin | CTD | PMID:33609687 |
Atg5 | Rat | trovafloxacin | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | trovafloxacin results in increased expression of ATG5 mRNA | CTD | PMID:33609687 |
Atg5 | Rat | trovafloxacin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | ATG5 protein affects the reaction [trovafloxacin results in increased cleavage of CASP3 protein] more ... | CTD | PMID:33609687 |
Atg5 | Rat | tunicamycin | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | Curcumin inhibits the reaction [Tunicamycin results in increased expression of ATG5 protein] | CTD | PMID:36640941 |
Atg5 | Rat | tunicamycin | increases expression | EXP | | 6480464 | Tunicamycin results in increased expression of ATG5 mRNA and Tunicamycin results in increased expression of ATG5 protein | CTD | PMID:37654027 |
Atg5 | Rat | tunicamycin | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Tunicamycin results in increased expression of ATG5 mRNA | CTD | PMID:29793971 |
Atg5 | Rat | tunicamycin | increases response to substance | ISO | Atg5 (Mus musculus) | 6480464 | ATG5 protein mutant form results in increased susceptibility to Tunicamycin | CTD | PMID:29793971 |
Atg5 | Rat | tunicamycin | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | [ATG5 protein mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of ATF4 mRNA more ... | CTD | PMID:29793971 |
Atg5 | Rat | tunicamycin | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of ATG5 protein | CTD | PMID:36640941 |
Atg5 | Rat | tyloxapol | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | Escin inhibits the reaction [tyloxapol results in decreased expression of ATG5 protein] | CTD | PMID:36905866 |
Atg5 | Rat | tyloxapol | decreases expression | ISO | Atg5 (Mus musculus) | 6480464 | tyloxapol results in decreased expression of ATG5 protein | CTD | PMID:36905866 |
Atg5 | Rat | valproic acid | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ATG5 mRNA | CTD | PMID:23527032 |
Atg5 | Rat | valproic acid | decreases expression | ISO | ATG5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ATG5 mRNA | CTD | PMID:27188386 |
Atg5 | Rat | valproic acid | affects expression | ISO | ATG5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ATG5 mRNA | CTD | PMID:23179753 |
Atg5 | Rat | vitamin E | multiple interactions | EXP | | 6480464 | Vitamin E inhibits the reaction [Doxorubicin results in increased expression of ATG5 mRNA] | CTD | PMID:38997059 |
Atg5 | Rat | vorinostat | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [sorafenib co-treated with vorinostat] promotes the reaction [FAS protein binds to CASP8 protein binds to ATG5 protein binds to HSPA5 protein] more ... | CTD | PMID:18787411 and PMID:20543569 |
Atg5 | Rat | vorinostat | increases expression | ISO | ATG5 (Homo sapiens) | 6480464 | vorinostat results in increased expression of ATG5 mRNA | CTD | PMID:27188386 |
Atg5 | Rat | zearalenone | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Zearalenone results in increased expression of ATG5 mRNA and Zearalenone results in increased expression of ATG5 protein | CTD | PMID:34537261 |
Atg5 | Rat | zinc atom | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ATG5 mRNA | CTD | PMID:18593933 |
Atg5 | Rat | zinc oxide | increases expression | ISO | Atg5 (Mus musculus) | 6480464 | Zinc Oxide analog results in increased expression of ATG5 mRNA | CTD | PMID:24614525 |
Atg5 | Rat | zinc oxide | increases expression | EXP | | 6480464 | Zinc Oxide results in increased expression of ATG5 mRNA | CTD | PMID:32951350 |
Atg5 | Rat | zinc oxide | multiple interactions | ISO | Atg5 (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG5 mRNA] | CTD | PMID:24614525 |
Atg5 | Rat | zinc(0) | multiple interactions | ISO | ATG5 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of ATG5 mRNA | CTD | PMID:18593933 |